ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pillApproval supported by four phase 3 studies that met ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results